Chad Bousman

The broad vision of my research is to discover, develop, and evaluate genomic-based tools with the utility to guide clinical decision-making and improve mental health outcomes. My primary focus is on optimizing the selection and dosing of drug therapies used to treat depression and schizophrenia. However, I am also actively involved in research examining the interactive effect genes and environments have on the brains of those with mental health problems.